Amneal Pharmaceuticals (AMRX) EV to EBITDA (2018 - 2026)
Amneal Pharmaceuticals' EV to EBITDA came in at 10.12 for Q3 2026, up 109.8% from 4.83 a year earlier and up 21.5% from the prior quarter.
Amneal Pharmaceuticals (AMRX) EV to EBITDA (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Amneal Pharmaceuticals reported EV to EBITDA of 9.24, up 108.1% year-over-year; for FY2025, it was 5.87, up 25.5% from FY2024.
- EV to EBITDA has increased in each of the last four years.
- Going back by year, EV to EBITDA was 4.68 in FY2024 (+15.2%), 4.06 in FY2023 (+3.7%), 3.92 in FY2022 (+27.7%) and 3.07 in FY2021 (-1.1%).
- The Q3 2026 figure represents the highest quarterly EV to EBITDA since Q3 2019.
- Year-over-year, EV to EBITDA has increased for four consecutive quarters, with growth averaging 33.4% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q2 2022 (growth of 129.6%), and the weakest in Q2 2023 (a decline of 72.8%).
- Business Quant data shows AMRX's EV to EBITDA at 8.33 (Q2 2026), 5.84 (Q1 2026) and 5.87 (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,304.70 Bn | 1,278.32 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 690.68 Bn | 610.54 Bn | 17.30 Bn |
| 3 | AbbVie | 528.28 Bn | 496.29 Bn | 13.12 Bn |
| 4 | Merck | 365.24 Bn | 328.18 Bn | 13.19 Bn |
| 5 | Novartis Ag | 314.66 Bn | 287.90 Bn | - |
| 6 | Astrazeneca | 288.53 Bn | 262.05 Bn | 13.26 Bn |
| 7 | Amgen | 253.39 Bn | 205.04 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.48 Bn | 185.59 Bn | 6.73 Bn |
| 9 | Pfizer | 165.27 Bn | 112.63 Bn | 12.56 Bn |
| 10 | Amneal Pharmaceuticals | 7.17 Bn | 6.41 Bn | 334.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.12 |
| Jun 30, 2026 | 8.33 |
| Mar 31, 2026 | 5.84 |
| Dec 31, 2025 | 5.87 |
| Sep 30, 2025 | 4.83 |
| Jun 30, 2025 | 3.85 |
| Mar 31, 2025 | 4.16 |
| Dec 31, 2024 | 4.66 |
| Sep 30, 2024 | 5.78 |
| Jun 30, 2024 | 4.61 |
| Mar 31, 2024 | 4.57 |
| Dec 31, 2023 | 4.00 |
| Sep 30, 2023 | 2.61 |
| Jun 30, 2023 | 2.13 |
| Mar 31, 2023 | 2.30 |
| Dec 31, 2022 | 4.93 |
| Sep 30, 2022 | 5.60 |
| Jun 30, 2022 | 7.82 |
| Mar 31, 2022 | 2.84 |
| Dec 31, 2021 | 3.06 |
Amneal Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();